カテゴリー： 世界, 医療/バイオ, LP Information

世界の疼痛治療注射市場予測 2023年-2029年

【英語タイトル】Global Pain Therapeutic Injection Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC03039）・商品コード：LP23DC03039
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：119
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥549,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥823,500見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,098,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の疼痛治療注射市場」は、過去の販売実績から2022年の世界の疼痛治療注射の総販売量を検討し、2023年から2029年の予測される疼痛治療注射の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の疼痛治療注射の市場規模を掲載し、XXX百万米ドル規模の世界の疼痛治療注射市場の詳細な分析を提供します。本インサイトレポートは、世界の疼痛治療注射業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の疼痛治療注射市場における各社の独自のポジションをより深く理解するために、疼痛治療注射製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の疼痛治療注射市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。疼痛治療注射の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。疼痛治療注射の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。疼痛治療注射のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

疼痛治療注射の世界主要メーカーとしては、AbbVie Inc.、 Bristol Myers Squibb Co.、 Sanofi S.A.、 Boehringer Ingelheim International GmbH、 Pfizer Inc.、 Zydus Lifesciences Ltd.、 GSK plc.、 Abbott Laboratories, Inc.、 Novartis AG、 Johnson & Johnson、 Teva Pharmaceuticals Ltd.、 Mallinckrodt Pharmaceuticals、 Bayer AG、 F. Hoffmann-La Roche Ltd.、 AstraZeneca、 Cardinal Health、 Perrigo Company Plc.、 Bausch Health Companies Inc.などを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の疼痛治療注射市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では疼痛治療注射市場をセグメンテーションし、種類別 (一般用医薬品、医療用医薬品)、用途別 (病院薬局、小売薬局、オンライン薬局)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：一般用医薬品、医療用医薬品

・用途別区分：病院薬局、小売薬局、オンライン薬局

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の疼痛治療注射市場の10年間の市場状況・展望は？
・世界および地域別に見た疼痛治療注射市場成長の要因は何か？
・疼痛治療注射の市場機会はエンドマーケットの規模によってどのように変化するのか？
・疼痛治療注射のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：疼痛治療注射の年間販売量2018-2029、地域別現状・将来分析
・疼痛治療注射の種類別セグメント：一般用医薬品、医療用医薬品
・疼痛治療注射の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・疼痛治療注射の用途別セグメント：病院薬局、小売薬局、オンライン薬局
・疼痛治療注射の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の疼痛治療注射市場
・企業別のグローバル疼痛治療注射市場データ：2018-2023年の年間販売量、市場シェア
・企業別の疼痛治療注射の年間売上：2018-2023年の売上、市場シェア
・企業別の疼痛治療注射販売価格
・主要企業の疼痛治療注射生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

疼痛治療注射の地域別レビュー
・地域別の疼痛治療注射市場規模2018-2023：年間販売量、売上
・主要国別の疼痛治療注射市場規模2018-2023：年間販売量、売上
・南北アメリカの疼痛治療注射販売の成長
・アジア太平洋の疼痛治療注射販売の成長
・ヨーロッパの疼痛治療注射販売の成長
・中東・アフリカの疼痛治療注射販売の成長

南北アメリカ市場
・南北アメリカの国別の疼痛治療注射販売量、売上（2018-2023）
・南北アメリカの疼痛治療注射の種類別販売量
・南北アメリカの疼痛治療注射の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の疼痛治療注射販売量、売上（2018-2023）
・アジア太平洋の疼痛治療注射の種類別販売量
・アジア太平洋の疼痛治療注射の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の疼痛治療注射販売量、売上（2018-2023）
・ヨーロッパの疼痛治療注射の種類別販売量
・ヨーロッパの疼痛治療注射の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の疼痛治療注射販売量、売上（2018-2023）
・中東・アフリカの疼痛治療注射の種類別販売量
・中東・アフリカの疼痛治療注射の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・疼痛治療注射の製造コスト構造分析
・疼痛治療注射の製造プロセス分析
・疼痛治療注射の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・疼痛治療注射の主要なグローバル販売業者
・疼痛治療注射の主要なグローバル顧客

地域別の疼痛治療注射市場予測レビュー
・地域別の疼痛治療注射市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・疼痛治療注射の種類別市場規模予測
・疼痛治療注射の用途別市場規模予測

主要企業分析
AbbVie Inc.、 Bristol Myers Squibb Co.、 Sanofi S.A.、 Boehringer Ingelheim International GmbH、 Pfizer Inc.、 Zydus Lifesciences Ltd.、 GSK plc.、 Abbott Laboratories, Inc.、 Novartis AG、 Johnson & Johnson、 Teva Pharmaceuticals Ltd.、 Mallinckrodt Pharmaceuticals、 Bayer AG、 F. Hoffmann-La Roche Ltd.、 AstraZeneca、 Cardinal Health、 Perrigo Company Plc.、 Bausch Health Companies Inc.
・企業情報
・疼痛治療注射製品
・疼痛治療注射販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Pain Therapeutic Injection market size is projected to grow from US$ 18880 million in 2022 to US$ 25980 million in 2029; it is expected to grow at a CAGR of 4.7% from 2023 to 2029.
United States market for Pain Therapeutic Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pain Therapeutic Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pain Therapeutic Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pain Therapeutic Injection players cover AbbVie Inc., Bristol Myers Squibb Co., Sanofi S.A., Boehringer Ingelheim International GmbH, Pfizer Inc., Zydus Lifesciences Ltd., GSK plc., Abbott Laboratories, Inc. and Novartis AG, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Pain Therapeutic Injectable is administered directly into the joint, where they are formulated to reduce inflammation and pain. Once injected into the joint, pain relief is almost immediate.
LPI (LP Information)’ newest research report, the “Pain Therapeutic Injection Industry Forecast” looks at past sales and reviews total world Pain Therapeutic Injection sales in 2022, providing a comprehensive analysis by region and market sector of projected Pain Therapeutic Injection sales for 2023 through 2029. With Pain Therapeutic Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pain Therapeutic Injection industry.
This Insight Report provides a comprehensive analysis of the global Pain Therapeutic Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pain Therapeutic Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pain Therapeutic Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pain Therapeutic Injection and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pain Therapeutic Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Pain Therapeutic Injection market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
OTC Drugs
Prescription Drugs
Segmentation by application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
AbbVie Inc.
Bristol Myers Squibb Co.
Sanofi S.A.
Boehringer Ingelheim International GmbH
Pfizer Inc.
Zydus Lifesciences Ltd.
GSK plc.
Abbott Laboratories, Inc.
Novartis AG
Johnson & Johnson
Teva Pharmaceuticals Ltd.
Mallinckrodt Pharmaceuticals
Bayer AG
F. Hoffmann-La Roche Ltd.
AstraZeneca
Cardinal Health
Perrigo Company Plc.
Bausch Health Companies Inc.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pain Therapeutic Injection market?
What factors are driving Pain Therapeutic Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pain Therapeutic Injection market opportunities vary by end market size?
How does Pain Therapeutic Injection break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pain Therapeutic Injection Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Pain Therapeutic Injection by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Pain Therapeutic Injection by Country/Region, 2018, 2022 & 2029
2.2 Pain Therapeutic Injection Segment by Type
2.2.1 OTC Drugs
2.2.2 Prescription Drugs
2.3 Pain Therapeutic Injection Sales by Type
2.3.1 Global Pain Therapeutic Injection Sales Market Share by Type (2018-2023)
2.3.2 Global Pain Therapeutic Injection Revenue and Market Share by Type (2018-2023)
2.3.3 Global Pain Therapeutic Injection Sale Price by Type (2018-2023)
2.4 Pain Therapeutic Injection Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Pain Therapeutic Injection Sales by Application
2.5.1 Global Pain Therapeutic Injection Sale Market Share by Application (2018-2023)
2.5.2 Global Pain Therapeutic Injection Revenue and Market Share by Application (2018-2023)
2.5.3 Global Pain Therapeutic Injection Sale Price by Application (2018-2023)
3 Global Pain Therapeutic Injection by Company
3.1 Global Pain Therapeutic Injection Breakdown Data by Company
3.1.1 Global Pain Therapeutic Injection Annual Sales by Company (2018-2023)
3.1.2 Global Pain Therapeutic Injection Sales Market Share by Company (2018-2023)
3.2 Global Pain Therapeutic Injection Annual Revenue by Company (2018-2023)
3.2.1 Global Pain Therapeutic Injection Revenue by Company (2018-2023)
3.2.2 Global Pain Therapeutic Injection Revenue Market Share by Company (2018-2023)
3.3 Global Pain Therapeutic Injection Sale Price by Company
3.4 Key Manufacturers Pain Therapeutic Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pain Therapeutic Injection Product Location Distribution
3.4.2 Players Pain Therapeutic Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Pain Therapeutic Injection by Geographic Region
4.1 World Historic Pain Therapeutic Injection Market Size by Geographic Region (2018-2023)
4.1.1 Global Pain Therapeutic Injection Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Pain Therapeutic Injection Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Pain Therapeutic Injection Market Size by Country/Region (2018-2023)
4.2.1 Global Pain Therapeutic Injection Annual Sales by Country/Region (2018-2023)
4.2.2 Global Pain Therapeutic Injection Annual Revenue by Country/Region (2018-2023)
4.3 Americas Pain Therapeutic Injection Sales Growth
4.4 APAC Pain Therapeutic Injection Sales Growth
4.5 Europe Pain Therapeutic Injection Sales Growth
4.6 Middle East & Africa Pain Therapeutic Injection Sales Growth
5 Americas
5.1 Americas Pain Therapeutic Injection Sales by Country
5.1.1 Americas Pain Therapeutic Injection Sales by Country (2018-2023)
5.1.2 Americas Pain Therapeutic Injection Revenue by Country (2018-2023)
5.2 Americas Pain Therapeutic Injection Sales by Type
5.3 Americas Pain Therapeutic Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pain Therapeutic Injection Sales by Region
6.1.1 APAC Pain Therapeutic Injection Sales by Region (2018-2023)
6.1.2 APAC Pain Therapeutic Injection Revenue by Region (2018-2023)
6.2 APAC Pain Therapeutic Injection Sales by Type
6.3 APAC Pain Therapeutic Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pain Therapeutic Injection by Country
7.1.1 Europe Pain Therapeutic Injection Sales by Country (2018-2023)
7.1.2 Europe Pain Therapeutic Injection Revenue by Country (2018-2023)
7.2 Europe Pain Therapeutic Injection Sales by Type
7.3 Europe Pain Therapeutic Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pain Therapeutic Injection by Country
8.1.1 Middle East & Africa Pain Therapeutic Injection Sales by Country (2018-2023)
8.1.2 Middle East & Africa Pain Therapeutic Injection Revenue by Country (2018-2023)
8.2 Middle East & Africa Pain Therapeutic Injection Sales by Type
8.3 Middle East & Africa Pain Therapeutic Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pain Therapeutic Injection
10.3 Manufacturing Process Analysis of Pain Therapeutic Injection
10.4 Industry Chain Structure of Pain Therapeutic Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pain Therapeutic Injection Distributors
11.3 Pain Therapeutic Injection Customer
12 World Forecast Review for Pain Therapeutic Injection by Geographic Region
12.1 Global Pain Therapeutic Injection Market Size Forecast by Region
12.1.1 Global Pain Therapeutic Injection Forecast by Region (2024-2029)
12.1.2 Global Pain Therapeutic Injection Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pain Therapeutic Injection Forecast by Type
12.7 Global Pain Therapeutic Injection Forecast by Application
13 Key Players Analysis
13.1 AbbVie Inc.
13.1.1 AbbVie Inc. Company Information
13.1.2 AbbVie Inc. Pain Therapeutic Injection Product Portfolios and Specifications
13.1.3 AbbVie Inc. Pain Therapeutic Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 AbbVie Inc. Main Business Overview
13.1.5 AbbVie Inc. Latest Developments
13.2 Bristol Myers Squibb Co.
13.2.1 Bristol Myers Squibb Co. Company Information
13.2.2 Bristol Myers Squibb Co. Pain Therapeutic Injection Product Portfolios and Specifications
13.2.3 Bristol Myers Squibb Co. Pain Therapeutic Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Bristol Myers Squibb Co. Main Business Overview
13.2.5 Bristol Myers Squibb Co. Latest Developments
13.3 Sanofi S.A.
13.3.1 Sanofi S.A. Company Information
13.3.2 Sanofi S.A. Pain Therapeutic Injection Product Portfolios and Specifications
13.3.3 Sanofi S.A. Pain Therapeutic Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Sanofi S.A. Main Business Overview
13.3.5 Sanofi S.A. Latest Developments
13.4 Boehringer Ingelheim International GmbH
13.4.1 Boehringer Ingelheim International GmbH Company Information
13.4.2 Boehringer Ingelheim International GmbH Pain Therapeutic Injection Product Portfolios and Specifications
13.4.3 Boehringer Ingelheim International GmbH Pain Therapeutic Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Boehringer Ingelheim International GmbH Main Business Overview
13.4.5 Boehringer Ingelheim International GmbH Latest Developments
13.5 Pfizer Inc.
13.5.1 Pfizer Inc. Company Information
13.5.2 Pfizer Inc. Pain Therapeutic Injection Product Portfolios and Specifications
13.5.3 Pfizer Inc. Pain Therapeutic Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Pfizer Inc. Main Business Overview
13.5.5 Pfizer Inc. Latest Developments
13.6 Zydus Lifesciences Ltd.
13.6.1 Zydus Lifesciences Ltd. Company Information
13.6.2 Zydus Lifesciences Ltd. Pain Therapeutic Injection Product Portfolios and Specifications
13.6.3 Zydus Lifesciences Ltd. Pain Therapeutic Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Zydus Lifesciences Ltd. Main Business Overview
13.6.5 Zydus Lifesciences Ltd. Latest Developments
13.7 GSK plc.
13.7.1 GSK plc. Company Information
13.7.2 GSK plc. Pain Therapeutic Injection Product Portfolios and Specifications
13.7.3 GSK plc. Pain Therapeutic Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 GSK plc. Main Business Overview
13.7.5 GSK plc. Latest Developments
13.8 Abbott Laboratories, Inc.
13.8.1 Abbott Laboratories, Inc. Company Information
13.8.2 Abbott Laboratories, Inc. Pain Therapeutic Injection Product Portfolios and Specifications
13.8.3 Abbott Laboratories, Inc. Pain Therapeutic Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Abbott Laboratories, Inc. Main Business Overview
13.8.5 Abbott Laboratories, Inc. Latest Developments
13.9 Novartis AG
13.9.1 Novartis AG Company Information
13.9.2 Novartis AG Pain Therapeutic Injection Product Portfolios and Specifications
13.9.3 Novartis AG Pain Therapeutic Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Novartis AG Main Business Overview
13.9.5 Novartis AG Latest Developments
13.10 Johnson & Johnson
13.10.1 Johnson & Johnson Company Information
13.10.2 Johnson & Johnson Pain Therapeutic Injection Product Portfolios and Specifications
13.10.3 Johnson & Johnson Pain Therapeutic Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Johnson & Johnson Main Business Overview
13.10.5 Johnson & Johnson Latest Developments
13.11 Teva Pharmaceuticals Ltd.
13.11.1 Teva Pharmaceuticals Ltd. Company Information
13.11.2 Teva Pharmaceuticals Ltd. Pain Therapeutic Injection Product Portfolios and Specifications
13.11.3 Teva Pharmaceuticals Ltd. Pain Therapeutic Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Teva Pharmaceuticals Ltd. Main Business Overview
13.11.5 Teva Pharmaceuticals Ltd. Latest Developments
13.12 Mallinckrodt Pharmaceuticals
13.12.1 Mallinckrodt Pharmaceuticals Company Information
13.12.2 Mallinckrodt Pharmaceuticals Pain Therapeutic Injection Product Portfolios and Specifications
13.12.3 Mallinckrodt Pharmaceuticals Pain Therapeutic Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Mallinckrodt Pharmaceuticals Main Business Overview
13.12.5 Mallinckrodt Pharmaceuticals Latest Developments
13.13 Bayer AG
13.13.1 Bayer AG Company Information
13.13.2 Bayer AG Pain Therapeutic Injection Product Portfolios and Specifications
13.13.3 Bayer AG Pain Therapeutic Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Bayer AG Main Business Overview
13.13.5 Bayer AG Latest Developments
13.14 F. Hoffmann-La Roche Ltd.
13.14.1 F. Hoffmann-La Roche Ltd. Company Information
13.14.2 F. Hoffmann-La Roche Ltd. Pain Therapeutic Injection Product Portfolios and Specifications
13.14.3 F. Hoffmann-La Roche Ltd. Pain Therapeutic Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 F. Hoffmann-La Roche Ltd. Main Business Overview
13.14.5 F. Hoffmann-La Roche Ltd. Latest Developments
13.15 AstraZeneca
13.15.1 AstraZeneca Company Information
13.15.2 AstraZeneca Pain Therapeutic Injection Product Portfolios and Specifications
13.15.3 AstraZeneca Pain Therapeutic Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 AstraZeneca Main Business Overview
13.15.5 AstraZeneca Latest Developments
13.16 Cardinal Health
13.16.1 Cardinal Health Company Information
13.16.2 Cardinal Health Pain Therapeutic Injection Product Portfolios and Specifications
13.16.3 Cardinal Health Pain Therapeutic Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Cardinal Health Main Business Overview
13.16.5 Cardinal Health Latest Developments
13.17 Perrigo Company Plc.
13.17.1 Perrigo Company Plc. Company Information
13.17.2 Perrigo Company Plc. Pain Therapeutic Injection Product Portfolios and Specifications
13.17.3 Perrigo Company Plc. Pain Therapeutic Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Perrigo Company Plc. Main Business Overview
13.17.5 Perrigo Company Plc. Latest Developments
13.18 Bausch Health Companies Inc.
13.18.1 Bausch Health Companies Inc. Company Information
13.18.2 Bausch Health Companies Inc. Pain Therapeutic Injection Product Portfolios and Specifications
13.18.3 Bausch Health Companies Inc. Pain Therapeutic Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Bausch Health Companies Inc. Main Business Overview
13.18.5 Bausch Health Companies Inc. Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Pain Therapeutic Injection Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Pain Therapeutic Injection Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of OTC Drugs
Table 4. Major Players of Prescription Drugs
Table 5. Global Pain Therapeutic Injection Sales by Type (2018-2023) & (K Units)
Table 6. Global Pain Therapeutic Injection Sales Market Share by Type (2018-2023)
Table 7. Global Pain Therapeutic Injection Revenue by Type (2018-2023) & ($ million)
Table 8. Global Pain Therapeutic Injection Revenue Market Share by Type (2018-2023)
Table 9. Global Pain Therapeutic Injection Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Pain Therapeutic Injection Sales by Application (2018-2023) & (K Units)
Table 11. Global Pain Therapeutic Injection Sales Market Share by Application (2018-2023)
Table 12. Global Pain Therapeutic Injection Revenue by Application (2018-2023)
Table 13. Global Pain Therapeutic Injection Revenue Market Share by Application (2018-2023)
Table 14. Global Pain Therapeutic Injection Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Pain Therapeutic Injection Sales by Company (2018-2023) & (K Units)
Table 16. Global Pain Therapeutic Injection Sales Market Share by Company (2018-2023)
Table 17. Global Pain Therapeutic Injection Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Pain Therapeutic Injection Revenue Market Share by Company (2018-2023)
Table 19. Global Pain Therapeutic Injection Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Pain Therapeutic Injection Producing Area Distribution and Sales Area
Table 21. Players Pain Therapeutic Injection Products Offered
Table 22. Pain Therapeutic Injection Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Pain Therapeutic Injection Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Pain Therapeutic Injection Sales Market Share Geographic Region (2018-2023)
Table 27. Global Pain Therapeutic Injection Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Pain Therapeutic Injection Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Pain Therapeutic Injection Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Pain Therapeutic Injection Sales Market Share by Country/Region (2018-2023)
Table 31. Global Pain Therapeutic Injection Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Pain Therapeutic Injection Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Pain Therapeutic Injection Sales by Country (2018-2023) & (K Units)
Table 34. Americas Pain Therapeutic Injection Sales Market Share by Country (2018-2023)
Table 35. Americas Pain Therapeutic Injection Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Pain Therapeutic Injection Revenue Market Share by Country (2018-2023)
Table 37. Americas Pain Therapeutic Injection Sales by Type (2018-2023) & (K Units)
Table 38. Americas Pain Therapeutic Injection Sales by Application (2018-2023) & (K Units)
Table 39. APAC Pain Therapeutic Injection Sales by Region (2018-2023) & (K Units)
Table 40. APAC Pain Therapeutic Injection Sales Market Share by Region (2018-2023)
Table 41. APAC Pain Therapeutic Injection Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Pain Therapeutic Injection Revenue Market Share by Region (2018-2023)
Table 43. APAC Pain Therapeutic Injection Sales by Type (2018-2023) & (K Units)
Table 44. APAC Pain Therapeutic Injection Sales by Application (2018-2023) & (K Units)
Table 45. Europe Pain Therapeutic Injection Sales by Country (2018-2023) & (K Units)
Table 46. Europe Pain Therapeutic Injection Sales Market Share by Country (2018-2023)
Table 47. Europe Pain Therapeutic Injection Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Pain Therapeutic Injection Revenue Market Share by Country (2018-2023)
Table 49. Europe Pain Therapeutic Injection Sales by Type (2018-2023) & (K Units)
Table 50. Europe Pain Therapeutic Injection Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Pain Therapeutic Injection Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Pain Therapeutic Injection Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Pain Therapeutic Injection Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Pain Therapeutic Injection Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Pain Therapeutic Injection Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Pain Therapeutic Injection Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Pain Therapeutic Injection
Table 58. Key Market Challenges & Risks of Pain Therapeutic Injection
Table 59. Key Industry Trends of Pain Therapeutic Injection
Table 60. Pain Therapeutic Injection Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Pain Therapeutic Injection Distributors List
Table 63. Pain Therapeutic Injection Customer List
Table 64. Global Pain Therapeutic Injection Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Pain Therapeutic Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Pain Therapeutic Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Pain Therapeutic Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Pain Therapeutic Injection Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Pain Therapeutic Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Pain Therapeutic Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Pain Therapeutic Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Pain Therapeutic Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Pain Therapeutic Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Pain Therapeutic Injection Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Pain Therapeutic Injection Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Pain Therapeutic Injection Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Pain Therapeutic Injection Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. AbbVie Inc. Basic Information, Pain Therapeutic Injection Manufacturing Base, Sales Area and Its Competitors
Table 79. AbbVie Inc. Pain Therapeutic Injection Product Portfolios and Specifications
Table 80. AbbVie Inc. Pain Therapeutic Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. AbbVie Inc. Main Business
Table 82. AbbVie Inc. Latest Developments
Table 83. Bristol Myers Squibb Co. Basic Information, Pain Therapeutic Injection Manufacturing Base, Sales Area and Its Competitors
Table 84. Bristol Myers Squibb Co. Pain Therapeutic Injection Product Portfolios and Specifications
Table 85. Bristol Myers Squibb Co. Pain Therapeutic Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Bristol Myers Squibb Co. Main Business
Table 87. Bristol Myers Squibb Co. Latest Developments
Table 88. Sanofi S.A. Basic Information, Pain Therapeutic Injection Manufacturing Base, Sales Area and Its Competitors
Table 89. Sanofi S.A. Pain Therapeutic Injection Product Portfolios and Specifications
Table 90. Sanofi S.A. Pain Therapeutic Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Sanofi S.A. Main Business
Table 92. Sanofi S.A. Latest Developments
Table 93. Boehringer Ingelheim International GmbH Basic Information, Pain Therapeutic Injection Manufacturing Base, Sales Area and Its Competitors
Table 94. Boehringer Ingelheim International GmbH Pain Therapeutic Injection Product Portfolios and Specifications
Table 95. Boehringer Ingelheim International GmbH Pain Therapeutic Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Boehringer Ingelheim International GmbH Main Business
Table 97. Boehringer Ingelheim International GmbH Latest Developments
Table 98. Pfizer Inc. Basic Information, Pain Therapeutic Injection Manufacturing Base, Sales Area and Its Competitors
Table 99. Pfizer Inc. Pain Therapeutic Injection Product Portfolios and Specifications
Table 100. Pfizer Inc. Pain Therapeutic Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Pfizer Inc. Main Business
Table 102. Pfizer Inc. Latest Developments
Table 103. Zydus Lifesciences Ltd. Basic Information, Pain Therapeutic Injection Manufacturing Base, Sales Area and Its Competitors
Table 104. Zydus Lifesciences Ltd. Pain Therapeutic Injection Product Portfolios and Specifications
Table 105. Zydus Lifesciences Ltd. Pain Therapeutic Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Zydus Lifesciences Ltd. Main Business
Table 107. Zydus Lifesciences Ltd. Latest Developments
Table 108. GSK plc. Basic Information, Pain Therapeutic Injection Manufacturing Base, Sales Area and Its Competitors
Table 109. GSK plc. Pain Therapeutic Injection Product Portfolios and Specifications
Table 110. GSK plc. Pain Therapeutic Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. GSK plc. Main Business
Table 112. GSK plc. Latest Developments
Table 113. Abbott Laboratories, Inc. Basic Information, Pain Therapeutic Injection Manufacturing Base, Sales Area and Its Competitors
Table 114. Abbott Laboratories, Inc. Pain Therapeutic Injection Product Portfolios and Specifications
Table 115. Abbott Laboratories, Inc. Pain Therapeutic Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Abbott Laboratories, Inc. Main Business
Table 117. Abbott Laboratories, Inc. Latest Developments
Table 118. Novartis AG Basic Information, Pain Therapeutic Injection Manufacturing Base, Sales Area and Its Competitors
Table 119. Novartis AG Pain Therapeutic Injection Product Portfolios and Specifications
Table 120. Novartis AG Pain Therapeutic Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Novartis AG Main Business
Table 122. Novartis AG Latest Developments
Table 123. Johnson & Johnson Basic Information, Pain Therapeutic Injection Manufacturing Base, Sales Area and Its Competitors
Table 124. Johnson & Johnson Pain Therapeutic Injection Product Portfolios and Specifications
Table 125. Johnson & Johnson Pain Therapeutic Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Johnson & Johnson Main Business
Table 127. Johnson & Johnson Latest Developments
Table 128. Teva Pharmaceuticals Ltd. Basic Information, Pain Therapeutic Injection Manufacturing Base, Sales Area and Its Competitors
Table 129. Teva Pharmaceuticals Ltd. Pain Therapeutic Injection Product Portfolios and Specifications
Table 130. Teva Pharmaceuticals Ltd. Pain Therapeutic Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Teva Pharmaceuticals Ltd. Main Business
Table 132. Teva Pharmaceuticals Ltd. Latest Developments
Table 133. Mallinckrodt Pharmaceuticals Basic Information, Pain Therapeutic Injection Manufacturing Base, Sales Area and Its Competitors
Table 134. Mallinckrodt Pharmaceuticals Pain Therapeutic Injection Product Portfolios and Specifications
Table 135. Mallinckrodt Pharmaceuticals Pain Therapeutic Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Mallinckrodt Pharmaceuticals Main Business
Table 137. Mallinckrodt Pharmaceuticals Latest Developments
Table 138. Bayer AG Basic Information, Pain Therapeutic Injection Manufacturing Base, Sales Area and Its Competitors
Table 139. Bayer AG Pain Therapeutic Injection Product Portfolios and Specifications
Table 140. Bayer AG Pain Therapeutic Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Bayer AG Main Business
Table 142. Bayer AG Latest Developments
Table 143. F. Hoffmann-La Roche Ltd. Basic Information, Pain Therapeutic Injection Manufacturing Base, Sales Area and Its Competitors
Table 144. F. Hoffmann-La Roche Ltd. Pain Therapeutic Injection Product Portfolios and Specifications
Table 145. F. Hoffmann-La Roche Ltd. Pain Therapeutic Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. F. Hoffmann-La Roche Ltd. Main Business
Table 147. F. Hoffmann-La Roche Ltd. Latest Developments
Table 148. AstraZeneca Basic Information, Pain Therapeutic Injection Manufacturing Base, Sales Area and Its Competitors
Table 149. AstraZeneca Pain Therapeutic Injection Product Portfolios and Specifications
Table 150. AstraZeneca Pain Therapeutic Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. AstraZeneca Main Business
Table 152. AstraZeneca Latest Developments
Table 153. Cardinal Health Basic Information, Pain Therapeutic Injection Manufacturing Base, Sales Area and Its Competitors
Table 154. Cardinal Health Pain Therapeutic Injection Product Portfolios and Specifications
Table 155. Cardinal Health Pain Therapeutic Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. Cardinal Health Main Business
Table 157. Cardinal Health Latest Developments
Table 158. Perrigo Company Plc. Basic Information, Pain Therapeutic Injection Manufacturing Base, Sales Area and Its Competitors
Table 159. Perrigo Company Plc. Pain Therapeutic Injection Product Portfolios and Specifications
Table 160. Perrigo Company Plc. Pain Therapeutic Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 161. Perrigo Company Plc. Main Business
Table 162. Perrigo Company Plc. Latest Developments
Table 163. Bausch Health Companies Inc. Basic Information, Pain Therapeutic Injection Manufacturing Base, Sales Area and Its Competitors
Table 164. Bausch Health Companies Inc. Pain Therapeutic Injection Product Portfolios and Specifications
Table 165. Bausch Health Companies Inc. Pain Therapeutic Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 166. Bausch Health Companies Inc. Main Business
Table 167. Bausch Health Companies Inc. Latest Developments
List of Figures
Figure 1. Picture of Pain Therapeutic Injection
Figure 2. Pain Therapeutic Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pain Therapeutic Injection Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Pain Therapeutic Injection Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Pain Therapeutic Injection Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of OTC Drugs
Figure 10. Product Picture of Prescription Drugs
Figure 11. Global Pain Therapeutic Injection Sales Market Share by Type in 2022
Figure 12. Global Pain Therapeutic Injection Revenue Market Share by Type (2018-2023)
Figure 13. Pain Therapeutic Injection Consumed in Hospital Pharmacies
Figure 14. Global Pain Therapeutic Injection Market: Hospital Pharmacies (2018-2023) & (K Units)
Figure 15. Pain Therapeutic Injection Consumed in Retail Pharmacies
Figure 16. Global Pain Therapeutic Injection Market: Retail Pharmacies (2018-2023) & (K Units)
Figure 17. Pain Therapeutic Injection Consumed in Online Pharmacies
Figure 18. Global Pain Therapeutic Injection Market: Online Pharmacies (2018-2023) & (K Units)
Figure 19. Global Pain Therapeutic Injection Sales Market Share by Application (2022)
Figure 20. Global Pain Therapeutic Injection Revenue Market Share by Application in 2022
Figure 21. Pain Therapeutic Injection Sales Market by Company in 2022 (K Units)
Figure 22. Global Pain Therapeutic Injection Sales Market Share by Company in 2022
Figure 23. Pain Therapeutic Injection Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Pain Therapeutic Injection Revenue Market Share by Company in 2022
Figure 25. Global Pain Therapeutic Injection Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Pain Therapeutic Injection Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Pain Therapeutic Injection Sales 2018-2023 (K Units)
Figure 28. Americas Pain Therapeutic Injection Revenue 2018-2023 ($ Millions)
Figure 29. APAC Pain Therapeutic Injection Sales 2018-2023 (K Units)
Figure 30. APAC Pain Therapeutic Injection Revenue 2018-2023 ($ Millions)
Figure 31. Europe Pain Therapeutic Injection Sales 2018-2023 (K Units)
Figure 32. Europe Pain Therapeutic Injection Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Pain Therapeutic Injection Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Pain Therapeutic Injection Revenue 2018-2023 ($ Millions)
Figure 35. Americas Pain Therapeutic Injection Sales Market Share by Country in 2022
Figure 36. Americas Pain Therapeutic Injection Revenue Market Share by Country in 2022
Figure 37. Americas Pain Therapeutic Injection Sales Market Share by Type (2018-2023)
Figure 38. Americas Pain Therapeutic Injection Sales Market Share by Application (2018-2023)
Figure 39. United States Pain Therapeutic Injection Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Pain Therapeutic Injection Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Pain Therapeutic Injection Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Pain Therapeutic Injection Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Pain Therapeutic Injection Sales Market Share by Region in 2022
Figure 44. APAC Pain Therapeutic Injection Revenue Market Share by Regions in 2022
Figure 45. APAC Pain Therapeutic Injection Sales Market Share by Type (2018-2023)
Figure 46. APAC Pain Therapeutic Injection Sales Market Share by Application (2018-2023)
Figure 47. China Pain Therapeutic Injection Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Pain Therapeutic Injection Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Pain Therapeutic Injection Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Pain Therapeutic Injection Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Pain Therapeutic Injection Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Pain Therapeutic Injection Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Pain Therapeutic Injection Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Pain Therapeutic Injection Sales Market Share by Country in 2022
Figure 55. Europe Pain Therapeutic Injection Revenue Market Share by Country in 2022
Figure 56. Europe Pain Therapeutic Injection Sales Market Share by Type (2018-2023)
Figure 57. Europe Pain Therapeutic Injection Sales Market Share by Application (2018-2023)
Figure 58. Germany Pain Therapeutic Injection Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Pain Therapeutic Injection Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Pain Therapeutic Injection Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Pain Therapeutic Injection Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Pain Therapeutic Injection Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Pain Therapeutic Injection Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Pain Therapeutic Injection Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Pain Therapeutic Injection Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Pain Therapeutic Injection Sales Market Share by Application (2018-2023)
Figure 67. Egypt Pain Therapeutic Injection Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Pain Therapeutic Injection Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Pain Therapeutic Injection Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Pain Therapeutic Injection Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Pain Therapeutic Injection Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Pain Therapeutic Injection in 2022
Figure 73. Manufacturing Process Analysis of Pain Therapeutic Injection
Figure 74. Industry Chain Structure of Pain Therapeutic Injection
Figure 75. Channels of Distribution
Figure 76. Global Pain Therapeutic Injection Sales Market Forecast by Region (2024-2029)
Figure 77. Global Pain Therapeutic Injection Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Pain Therapeutic Injection Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Pain Therapeutic Injection Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Pain Therapeutic Injection Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Pain Therapeutic Injection Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の疼痛治療注射市場予測 2023年-2029年] (コード：LP23DC03039)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の疼痛治療注射市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の獣医用鎮痛剤市場予測 2023年-2029年
  • 世界の治療用栄養素&ミネラル市場予測 2023年-2029年
  • 世界の粘着性鎮痛パッチ市場予測 2023年-2029年
  • 世界の静脈瘤治療用ソックス市場予測 2023年-2029年
  • 世界の核放射線治療薬市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆